Brown v. BNSF Railway Company

CourtDistrict Court, W.D. Washington
DecidedNovember 4, 2019
Docket2:19-cv-00746
StatusUnknown

This text of Brown v. BNSF Railway Company (Brown v. BNSF Railway Company) is published on Counsel Stack Legal Research, covering District Court, W.D. Washington primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Brown v. BNSF Railway Company, (W.D. Wash. 2019).

Opinion

6 UNITED STATES DISTRICT COURT WESTERN DISTRICT OF WASHINGTON 7 AT SEATTLE

8 GAYLEN BROWN, CASE NO. C19-746RSM

9 Plaintiff, ORDER GRANTING IN PART DEFENDANT’S MOTION TO COMPEL 10 v.

11 BNSF RAILWAY COMPANY, f/k/a Burlington Northern and Santa Fe Railway 12 Company,

13 Defendant.

14 15 This matter is before the Court on Defendant’s Motion to Compel, or in the Alternative, 16 Renewal of Request for a Modified Scheduling Order. Dkt. #12. Defendant was forced to file 17 this Motion seeking responses to Defendant BNSF Railway Company’s First Combined 18 Interrogatories and Requests for Production to Plaintiff. Alternatively, Defendant requests that 19 the Court require early and phased discovery as to Plaintiff’s experts. Id. at 3–4. Plaintiff has 20 subsequently responded to Defendant’s discovery requests. Dkt. #13 at 1–2. Despite receiving 21 responses, Defendant maintains that the responses “lacked substantive content” and does not 22 withdraw its Motion. The Court grants the Motion in part. 23 Plaintiff worked for Defendant and its predecessor for almost 20 years. Dkt. #1 at ¶ 6. 24 Following his employment, Plaintiff developed bladder cancer that he alleges was caused by his 1 exposure to “diesel fuel/fumes/exhaust, benzene, creosote, herbicides[,] and asbestos dust and 2 fibers” in the course of his employment. Id. at ¶¶ 7–11. Defendant’s central concern is that 3 Plaintiff’s Complaint does not “allege that any of the substances are known to cause bladder 4 cancer.” Dkt. #12 at 3. Defendant asserts that Plaintiff will ultimately have to “prove that a 5 specific substance causes the type of cancer at issue in the lawsuit.” Id. (citing Henricksen v.

6 Conoco Phillips Co., 605 F. Supp. 2d 1142 (E.D. Wash. 2009). Defendant thus argues that its 7 discovery is aimed at “narrowing the issues” and that phasing discovery as to experts can remove 8 claims that will not ultimately proceed. Dkt. #12 at 3–4. 9 Plaintiff has not opposed Defendant’s Motion, filing only an untimely response. See Dkt. 10 #15. Plaintiff provides no explanation for the untimely filing and the Court will not consider it. 11 To the extent necessary, the Court denies Plaintiff’s request for leave to file an untimely response. 12 The Court takes Plaintiff’s failure to respond as an admission that Defendant’s Motion has merit.” 13 See LCR 7(b)(2) (“Except for motions for summary judgment, if a party fails to file papers in 14 opposition to a motion, such failure may be considered by the court as an admission that the

15 motion has merit.”). The Court therefore considers what relief is appropriate. 16 The Court will not grant Defendant’s alternative request that the Court modify the 17 scheduling order to phase discovery. Specifically, Defendant requests that Plaintiff be required 18 to present, within 30 days, an affidavit of a qualified expert identifying (1) each specific 19 substance Plaintiff claims caused his cancer, (2) an expert who will testify as to each substance, 20 and (3) the supporting scientific and medical literature. See Dkt. #12-3 (Defendant’s proposed 21 order). On this record, the Court does not find good cause for departing from the normal course 22 of discovery or its scheduling order. Additionally, to the extent Defendant points to the 23 possibility of future harm absent its requested relief, Defendant is protected under the applicable 24 rules and can raise the issue with the Court when appropriate. ] The Court does, however, find that Plaintiff's discovery responses are insufficient and 2 ||non-responsive. See e.g. Dkt. #13-1 at 3. 3 INTERROGATORY NO. 3: With respect to creosote please identify: 4 (a) Who told you that your cancer was caused by creosote; 5 (b) For each individual, please state when it occurred; 6 (c) For each individual, please state whether that individual is an expert witness as defined by Federal Rule of Evidence 702 and if so, in what field; 7 (d) Identify the scientific and medical authorities that support a causal link between creosote and your cancer; (e) Identify all witnesses and all documents that you contend established 9 evidentiary support for your factual contention that creosote caused your cancer. 10 11 ANSWER: Plaintiff will respond in way of expert testimony. 12 || Accordingly, the Court finds that Defendant’s Motion should be granted to the extent it seeks 13 || substantive and complete responses to Defendant’s discovery requests. 14 Having reviewed Defendant’s Motion and the remainder of the record, the Court finds 15 ||and ORDERS that Defendant’s Motion to Compel, or in the Alternative, Renewal of Request for 16 ||a Modified Scheduling Order (Dkt. #12) is GRANTED IN PART. Within five (5) days of this 17 || Order, Plaintiff shall supplement his responses to Defendant BNSF Railway Company’s First 18 ||Combined Interrogatories and Requests for Production to Plaintiff to provide substantive and 19 || complete responses to each request. Plaintiff may not raise new objections. 20 DATED this 4 day of November 2019. 21 22 LAywtd > RICARDO S. MARTINEZ 23 CHIEF UNITED STATES DISTRICT JUDGE 24

ORDER — 3

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Henricksen v. ConocoPhillips Co.
605 F. Supp. 2d 1142 (E.D. Washington, 2009)

Cite This Page — Counsel Stack

Bluebook (online)
Brown v. BNSF Railway Company, Counsel Stack Legal Research, https://law.counselstack.com/opinion/brown-v-bnsf-railway-company-wawd-2019.